<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02871167</url>
  </required_header>
  <id_info>
    <org_study_id>CHACRY-1501</org_study_id>
    <secondary_id>2016-000808-28</secondary_id>
    <secondary_id>PHRC-K14-010</secondary_id>
    <nct_id>NCT02871167</nct_id>
  </id_info>
  <brief_title>Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation</brief_title>
  <acronym>CHACRY-1501</acronym>
  <official_title>Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Oscar Lambret</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Oscar Lambret</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to perform a French multicenter prospective interventional study in
      order to assess the feasibility and safety of ovarian hyperstimulation for oocyte / embryo
      cryopreservation in young women with breast cancer. The oncologic and reproductive benefit /
      risk ratio will be investigated in the oncology and reproductive area.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medical Oncology:

        -  Information and collection of consent,

        -  Imaging staging,

        -  Inclusion

        -  Physical examination

        -  Contraception advise given

      Reproductive medicine center:

        -  Ovarian reserve assessment: serum anti-mullerian hormone (AMH) measurement and antral
           follicle count (AFC) by ultrasound.

        -  Serology syphilis, hepatitis B and C, HIV (human immunodeficiency virus). In case of
           embryo cryopreservation, same serology determination for the men.

        -  Infertility risk and fertility preservation techniques information.

        -  In case of agreement, this technique will be done during the time-interval between
           surgery and chemotherapy

        -  Fertility preservation (COH stimulation, triggering and oocyte retrieval)

      Adjuvant chemotherapy:

        -  The chemotherapy regimen is 3 FEC (fluorouracil epirubicin cyclophosphamide) 100
           followed by standard chemotherapy (according to local practice) +/- Trastuzumab.
           Adjuvant chemotherapy may only begin after the oocyte retrieval.

        -  Usual adjuvant chemotherapy is not changed

      During chemotherapy:

        -  Clinical exam before each cycle of chemotherapy

        -  AMH, AFC at cycle 6

      After chemotherapy:

        -  Usual patient monitoring in expert center :

      physical examination at Month 3 (M3), M6 M9 M12 M18 and M24 and mammography at M9 then annual

        -  AMH at Month 3 (M3), M6 M9 M12 M18 and M24

        -  AFC at Month 12 (M12) and M24
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of oocytes: total number of oocytes preserved</measure>
    <time_frame>after oocyte retrieval (35-36 hours after triptorelin injection)</time_frame>
    <description>The distribution of the total number of oocytes preserved will be summarized by the mean (standard error) and median (range) and presented with a 95% confidence interval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of embryos: total number of embryos preserved</measure>
    <time_frame>at 44-46 hours post intra-cell sperm injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of oocytes</measure>
    <time_frame>after oocyte retrieval (35-36 hours after triptorelin injection)</time_frame>
    <description>mature, immature, fractured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity related to the controlled ovarian stimulation according to NCI CTCAE v4.0 scale</measure>
    <time_frame>24 months</time_frame>
    <description>Toxicities will be tabulated with frequencies and percentages by type of adverse events and by grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AMH measurement</measure>
    <time_frame>baseline, at the end of the first sequence of chemotherapy, at the last injection of treatment, at Month 3, Month 6, Month 9, Month 12, Month 18 and Month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antral Follicular Count (AFC) measurement</measure>
    <time_frame>baseline, at month 3, at month 12, at month 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Spontaneous or medically assisted pregnancy(ies)</measure>
    <time_frame>up to 10 years after the end of the study or at 43 years old</time_frame>
    <description>To measure the degree of project completion of subsequent pregnancy(ies)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients wishing for re-utilization of their frozen gametes</measure>
    <time_frame>up to 10 years after the end of the study or at 43 years old</time_frame>
    <description>To assess the number of patients wishing for re-utilization of their frozen gametes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>through study completion, an average of 5 years</time_frame>
    <description>defined as the interval between inclusion and the first occurrence of local, regional or distant relapse, estimated using the Kaplan-Meier method</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Translational research : circulating nucleic acids quantification: cell-free DNA and microRNAs on blood sample</measure>
    <time_frame>an average of 6 months</time_frame>
    <description>before 1st cycle of adjuvant chemotherapy, during the adjuvant chemotherapy (end of first sequence), at the end of adjuvant chemotherapy</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Oocyte/embryo cryopreservation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Controlled ovarian hyperstimulation (COH)
Oocyte/embryo freezing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Controlled ovarian hyperstimulation (COH)</intervention_name>
    <description>After information and consent, patients are addressed to a reproductive medicine center.
The COH will be performed according to a standardized protocol between surgery and the start of adjuvant chemotherapy. Follicular growth will be achieved with an antagonist protocol and by using high dose recombinant FSH (r-FSH). The triggering of the final follicular and oocyte maturation will be obtained by a GnRH (Gonadotropin Releasing Hormone) agonist injection in order to minimize the risk of ovarian hyper-stimulation.</description>
    <arm_group_label>Oocyte/embryo cryopreservation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oocyte/embryo freezing</intervention_name>
    <description>Egg or embryo freezing will be performed according to a standardized protocol: slow-freezing process for embryo; vitrification technique for oocytes. Cryopreserved oocytes and embryos will be stored in the biological bank of each reproductive medicine center (min. 10 years).</description>
    <arm_group_label>Oocyte/embryo cryopreservation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with histologically proven breast cancer

          -  Aged 18 to 38 years old

          -  Planned adjuvant chemotherapy

          -  No prior chemotherapy

          -  Affiliated to a public health insurance program

          -  Informed consent signed by the patient

        Exclusion Criteria:

          -  Metastatic breast cancer

          -  Planned neo-adjuvant chemotherapy

          -  Hysterectomy

          -  Exclusive adjuvant hormonotherapy

          -  Positive serology for syphilis, hepatitis B or C, or VIH

          -  Contraindication related to use of r-FSH

          -  Pregnant or breastfeeding patients
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Audrey Maillez, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Oscar Lambret</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Decanter, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHRU of Lille - Hôpital Jeanne de Flandre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Audrey Maillez, MD</last_name>
    <email>a-mailliez@o-lambret.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Decanter, MD</last_name>
    <phone>+33 3 20 44 68 97</phone>
    <email>c-decanter@chru-lille.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael GRYNBERG, PhD</last_name>
      <phone>0148026860</phone>
      <email>michael.grynberg@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Michael GRYNBERG, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Aliénor d'Aquitaine, Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa CONRI, MD</last_name>
      <phone>0557820941</phone>
      <email>vanessa.conri@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Vanessa CONRI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie TRUFFLANDIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine DENOUAL-ZIAD, MD</last_name>
      <phone>0231272059</phone>
      <email>denoualziad-c@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Christine DENOUAL-ZIAD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Djelila ALLOUACHE, MD</last_name>
      <phone>0231455002</phone>
      <email>dallouache@baclesse.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Djelila ALLOUACHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christelle LEVY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien GEFFRELOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carine SEGURA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katharina GUNZER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iona HRAB, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>George EMILE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey FAVEYRIAL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Antoine Béclère</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie SCARABIN-CARRE, MD</last_name>
      <phone>0145374201</phone>
      <email>valerie.scarabin@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Valérie SCARABIN-CARRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vanessa GALLOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion PRESSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Georges François LECLERC</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle DESMOULINS, MD</last_name>
      <email>IDesmoulins@cgfl.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle DESMOULINS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine LOUSTALOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles COUTANT, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clémentine JANKOWSKI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabrina DRIDI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien LE GALL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Martine PADEANO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvain LADOIRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno COUDERT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul SAGOT, PhD</last_name>
      <phone>0380293852</phone>
      <email>paul.sagot@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Paul SAGOT, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marjorie ROGER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU REUNION site SUD</name>
      <address>
        <city>La Réunion</city>
        <zip>97410</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène FLYE SAINTE MARIE, MD</last_name>
      <phone>02 62 71 75 92</phone>
      <email>helene.flye@chu-reunion.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène FLYE SAINTE MARIE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lam Foong Fat LAM KAM SANG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence LAÏ-TIONG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Béatrice NAYL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc GABRIELE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie FONTAINE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Coraline GARRAIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Maillez, MD</last_name>
      <phone>+33 3 20 29 59 18</phone>
      <email>a-mailliez@o-lambret.fr</email>
    </contact>
    <investigator>
      <last_name>Audrey MAILLIEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques BONNETERRE, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence VANLEMMENS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diane PANNIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natacha STERN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nawale HAJAJI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie KACZMAREK, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Hôpital Jeanne de Flandres</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine DECANTER, MD</last_name>
      <phone>0320446897</phone>
      <email>c-decanter@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Christine DECANTER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline PLOUVIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise-Marie DURAND, MD</last_name>
      <phone>0555058824</phone>
      <email>durandlisemarie@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Lise-Marie DURAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine LAVAU-DENES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence VENAT-BOUVET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves AUBARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal PIVER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69229</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno SALLE, MD</last_name>
      <phone>0472129411</phone>
      <email>bruno.salle@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno SALLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline SANTAMARIA-LORNAGE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine ROUSSET-JABLONSKI, MD</last_name>
      <phone>0478785129</phone>
      <email>christine.roussetjablonski@lyon.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Christine ROUSSET-JABLONSKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier TREDAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas BACHELOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle RAY-COQUART, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Etienne HEUDEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blandine COURBIERE, MD</last_name>
      <phone>0491383711</phone>
      <email>blandine.courbiere@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Blandine COURBIERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline BOTTIN-DUBERGE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline SAIAS-MAGNA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmette</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali PROVANSAL, MD</last_name>
      <phone>0491229740</phone>
      <email>provansalm@ipc.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Magali PROVANSAL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques CAMERLO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony GONCALVES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Marc EXTRA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole TARPIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud SABATIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie BRINGER-DEUTSCH, MD</last_name>
      <phone>0467336452</phone>
      <email>s-bringer_deutsch@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie BRINGER-DEUTSCH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gauthier RATHAT, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine TOPART, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire VINCENS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICM - Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Séverine GUIU, MD</last_name>
      <phone>0467613043</phone>
      <email>severin.guiu@icm.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Séverine GUIU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles ROMIEU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William JACOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique D'HONDT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie ALEXANDRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine DULIEGE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nelly FIRMIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane POUDEROUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie VIALA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikael AGOPIANTZ, MD</last_name>
      <phone>0671038224</phone>
      <email>m.agopiantz@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Mikael AGOPIANTZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine LAMY-ZUILY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence COUSSY, MD</last_name>
      <email>florence.coussy@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Florence COUSSY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Coraline DUBOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence COUSSY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie FOURCHOTTE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roman ROUZIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro SANTULLI, MD</last_name>
      <phone>0158413709</phone>
      <email>pietro.santulli@icch.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Pietro SANTULLI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathilde BOURDON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vanessa GAYET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chloé MAINGNIEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital TENON</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie CHABBERT-BUFFET, PhD</last_name>
      <email>nathalie.chabbert-buffet@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie CHABBERT-BUFFET, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre LOTZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph GLIGOROV, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle MATHIEU D'ARGENT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lise SELLERET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine RICHARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adoracion ESTESO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria LETAILLEUR, MD</last_name>
      <phone>02 32 88 87 44</phone>
      <email>Maria.Letailleur@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Maria LETAILLEUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne LEHEURTEUR, MD</last_name>
      <phone>0232082575</phone>
      <email>marianne.leheurteur@chb.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Marianne LEHEURTEUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Chirstophe THERY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel DE GOURNAY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Saint-Cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence COUSSY, MD</last_name>
      <email>florence.coussy@curie.fr</email>
    </contact>
    <investigator>
      <last_name>Florence COUSSY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anika BENSEN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie FRANCK, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Yves PIERGA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Clément BIDARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Etienne BRAIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc CABEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine HEQUET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florence LEREBOURS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuting WANG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier PIRRELLO, MD</last_name>
      <phone>0388628300</phone>
      <email>olivier.pirrello@CHRU-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Philippe BARTHELEMY, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Olivier PIRRELLO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe BARTHELEMY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure DE COCK, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanine OHL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine RONGIERES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncopole-CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clémentine COHADE, MD</last_name>
      <phone>0567771102</phone>
      <email>cohade.c@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Clémentine COHADE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean PARINAUD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger LEANDRI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion DESLANDRES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre les nancy</city>
        <zip>54519</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathilde DEBLOCK, MD</last_name>
      <phone>0383598574</phone>
      <email>m.deblock@nancy.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Mathilde DEBLOCK, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria RIOS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent MASSARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne KIEFFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lionel UWER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrica BENTIVEGNA, MD</last_name>
      <phone>0142115668</phone>
      <email>enrica.bentivegna@gustaveroussy.fr</email>
    </contact>
    <investigator>
      <last_name>Enrica BENTIVEGNA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suzette DELALOGE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2016</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oocyte/embryo cryopreservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

